What is the cure rate for hep c geno type 3 with sovaldi and ribavirin for 24 weeks!!!

New medication, TTYD: According to Gilead (maker of Solvadi), in their POSITRON trial, 61% of all pts with Type 3 HepC had a sustained virologic response (SVR) (lower Hep C virus blood counts) at 24 wks. See the package insert (PI) approved by the FDA: https://www.gilead.com/~/media/Files/pdfs/medicines/liver-disease/sovaldi/sovaldi_pi.pdf. In the trial, those w/o cirrhosis were 68% likely to have SVR. TTYD about this.